UK-India partnership unveils 'Living Lab' for Sustainable Pharma Manufacturing

A groundbreaking UK-India initiative, the ‘Living Laboratory’ was officially launched in Pune, India, marking a significant step toward decarbonizing the pharma industry. The state-of-the-art facility that will serve as a testing & demonstration hub for organizations to develop, evaluate, as well as implement advanced and sustainable manufacturing technologies for reducing greenhouse gas emissions and improving productivity.

Several major pharma firms such as Sun Pharma, Aarti Industries, Alivus Life Sciences, USV, Anthem Biosciences, Corning and GMM-Pfaudler have joined the partnership. Furthermore, mid-sized organizations have aligned with the Industry Consortium of Continuous Manufacturing for exploring innovative manufacturing processes.

Dr. Ashish Lele, Director of CSIR-NCL, stated: “The Living Lab will act as a unique testbed for the Indian chemical and pharmaceutical industries, validating emerging technologies and enabling the shift from batch to continuous manufacturing, leading to a significant reduction in emissions and waste.”

Sudarshan Jain, Secretary-General of the Indian Pharmaceutical Alliance (IPA), highlighted: “With increasing regulatory approvals for continuous manufacturing, the industry is embracing smart automation. The CPI UK-NCL India Living Lab will accelerate this transformation, fostering innovation and operational excellence on a global scale.”